Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed at $1.99 in the last session, up 2.58% from day before closing price of $1.94. In other words, the price has increased by $2.58 from its previous closing price. On the day, 2.54 million shares were traded. MRVI stock price reached its highest trading level at $2.15 during the session, while it also had its lowest trading level at $1.78.
Ratios:
We take a closer look at MRVI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.65 and its Current Ratio is at 7.53. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 1.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on February 26, 2025, Downgraded its rating to Neutral and sets its target price to $3 from $9 previously.
Goldman Downgraded its Neutral to Sell on December 05, 2024, while the target price for the stock was maintained at $4.25.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 31 ’25 when ORESHACK KURT sold 25,000 shares for $5.03 per share. The transaction valued at 125,750 led to the insider holds 167,618 shares of the business.
ORESHACK KURT bought 25,000 shares of MRVI for $125,750 on Jan 31 ’25. On Nov 12 ’24, another insider, DeFord John A, who serves as the Director of the company, bought 17,500 shares for $5.75 each. As a result, the insider paid 100,625 and bolstered with 70,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 493412544 and an Enterprise Value of 583519488. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.95 while its Price-to-Book (P/B) ratio in mrq is 0.87. Its current Enterprise Value per Revenue stands at 2.251 whereas that against EBITDA is -24.013.
Stock Price History:
The Beta on a monthly basis for MRVI is 0.24, which has changed by -0.76615745 over the last 52 weeks, in comparison to a change of -0.028342128 over the same period for the S&P500. Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $1.88. The 50-Day Moving Average of the stock is -40.83%, while the 200-Day Moving Average is calculated to be -68.46%.
Shares Statistics:
According to the various share statistics, MRVI traded on average about 3.37M shares per day over the past 3-months and 3012120 shares per day over the past 10 days. A total of 141.98M shares are outstanding, with a floating share count of 116.77M. Insiders hold about 18.71% of the company’s shares, while institutions hold 85.71% stake in the company. Shares short for MRVI as of 1741910400 were 11604523 with a Short Ratio of 3.45, compared to 1739491200 on 10300517. Therefore, it implies a Short% of Shares Outstanding of 11604523 and a Short% of Float of 9.609999499999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
